You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,580,282


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,580,282 protect, and when does it expire?

Patent 8,580,282 protects KOVANAZE and is included in one NDA.

This patent has twenty-six patent family members in sixteen countries.

Summary for Patent: 8,580,282
Title:Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
Abstract: The present invention relates to tetracaine based anesthetic formulations and methods of use thereof. The invention further relates to topical formulations of tetracaine and methods of topically anesthetizing body tissues. The present invention also relates to tetracaine based dental anesthetic formulations and methods for anesthetizing the maxillary dental arch using these formulations.
Inventor(s): Kollar; Mark David (Fort Collins, CO)
Assignee: St. Renatus, LLC (Fort Collins, CO)
Application Number:13/262,704
Patent Claim Types:
see list of patent claims
Composition; Use; Delivery; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,580,282

Introduction

United States Patent 8,580,282, like any other patent, is a complex document that outlines the invention, its claims, and the scope of protection it offers. To analyze this patent, we need to delve into its various components and the broader patent landscape.

Patent Overview

  • Patent Number: 8,580,282
  • Grant Date: This information is not provided in the search results, but it can be found through the USPTO's patent search tools[4].

Claims Analysis

The claims section of a patent is crucial as it defines the scope of the invention and what is protected by the patent.

Independent and Dependent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are the broadest claims in the patent.
  • Dependent Claims: These claims refer back to and further limit the independent claims, often adding specific details or features.

Claim Construction

Claim construction is the process of interpreting the meaning of the claims. This is critical in determining the scope of the patent and can be a point of contention in patent litigation.

Patent Scope

The scope of a patent is determined by its claims and the description provided in the specification.

Specification and Drawings

The specification and drawings provide a detailed description of the invention, including how it works and its various components. This section helps in understanding the context and limitations of the claims.

Prior Art and Novelty

To be patentable, an invention must be novel and non-obvious over the prior art. The patent landscape, including existing patents and publications, is crucial in determining this.

Patent Landscape

The patent landscape includes all relevant patents and publications that relate to the invention.

Related Patents and Applications

Using tools like the USPTO's Patent Public Search or Global Dossier, one can identify related patents and applications, including those in the same patent family or those that cite the patent in question[4].

Citation Data

The Common Citation Document (CCD) application can provide a consolidated view of prior art cited by multiple patent offices, helping to understand the global patent landscape[4].

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention that is obvious in view of a first patent. This is relevant if the patent in question is part of a larger patent family.

Terminal Disclaimers

In cases where ODP is an issue, terminal disclaimers may be used to overcome the rejection. This involves disclaiming the term of the later patent to ensure it does not extend beyond the term of the earlier patent[1].

Economic and Statistical Analysis

The USPTO provides various datasets and research tools that can help in analyzing the economic impact and statistical trends related to patents.

Patent Claims Research Dataset

This dataset contains detailed information on claims from US patents granted between 1976 and 2014, which can be used to analyze the scope and trends in patent claims[3].

Legal and Policy Considerations

The legal and policy framework surrounding patents is complex and evolving.

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address the needs of smaller inventors and businesses, highlighting the ongoing evolution of patent law and policy[5].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for determining the scope of the patent.
  • Patent Scope: The specification, drawings, and prior art are essential in interpreting the claims and determining the novelty and non-obviousness of the invention.
  • Patent Landscape: Tools like the USPTO's Patent Public Search and Global Dossier help in identifying related patents and understanding the global context.
  • ODP and Terminal Disclaimers: These are important considerations in managing patent families and ensuring compliance with patent laws.
  • Economic and Statistical Analysis: Datasets provided by the USPTO can help in analyzing the economic impact and trends in patent claims.

FAQs

Q: How do I search for a specific patent on the USPTO website? A: You can use the USPTO's Patent Public Search tool to find existing patents and published patent applications. This tool provides enhanced access to prior art and allows for detailed searches[4].

Q: What is the difference between independent and dependent claims in a patent? A: Independent claims stand alone and define the invention broadly, while dependent claims refer back to and further limit the independent claims by adding specific details or features.

Q: How does the USPTO handle obviousness-type double patenting (ODP)? A: The USPTO requires an ODP analysis to prevent an inventor from securing a second, later-expiring patent for an invention that is obvious in view of a first patent. Terminal disclaimers may be used to overcome ODP rejections[1].

Q: What resources are available for analyzing the economic impact of patents? A: The USPTO provides the Patent Claims Research Dataset, which contains detailed information on claims from US patents granted between 1976 and 2014. This dataset can be used to analyze the scope and trends in patent claims[3].

Q: Is there a proposal for a small claims patent court in the United States? A: Yes, the Administrative Conference of the United States (ACUS) has conducted a study on the feasibility and potential structure of a small claims patent court, which includes input from various stakeholders and legal experts[5].

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit[1].
  2. U.S. Patent and Trademark Office (USPTO) - USAGov[2].
  3. Patent Claims Research Dataset - USPTO[3].
  4. Search for patents - USPTO[4].
  5. U.S. Patent Small Claims Court - ACUS[5].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,580,282

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
St Renatus KOVANAZE oxymetazoline hydrochloride; tetracaine hydrochloride SPRAY, METERED;NASAL 208032-001 Jun 29, 2016 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y METHOD OF ANESTHETIZING AT LEAST A PORTION OF THE MAXILLARY DENTAL ARCH ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,580,282

PCT Information
PCT FiledApril 02, 2010PCT Application Number:PCT/US2010/001002
PCT Publication Date:October 07, 2010PCT Publication Number: WO2010/114622

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.